Daclahep Tablets

Daclahep Tablets


Daclahep contains daclatasvir 60 mg tablet (equivalent to daclatasvir dihydrochloride). Daclatasvir is a hepatitis C virus (HCV) NS5A inhibitor indicated for use with sofosbuvir for treatment of chronic HCV genotype 3 infection.


Daclahep 60 mg Tablet is used in the treatment of chronic hepatitis C virus (HCV) infection.

* To be consumed as directed by physician.

Product Enquiry